Literature DB >> 18440724

Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.

Kyoichi Kaira1, Noboru Oriuchi, Hisao Imai, Kimihiro Shimizu, Noriko Yanagitani, Noriaki Sunaga, Takeshi Hisada, Osamu Kawashima, Hironobu Iijima, Tamotsu Ishizuka, Yoshikatsu Kanai, Hitoshi Endou, Takashi Nakajima, Masatomo Mori.   

Abstract

Amino acid transport systems play an important role in cellular proliferation. L-type amino acid transporter 1 (LAT1) has been associated with tumor growth, and is highly expressed in the established tumor cell lines and primary human neoplasms. In this study, we investigated the expression of LAT1 to evaluate the malignant potential and prognostic significance in neuroendocrine (NE) tumors of the lung. Twenty-one surgically resected, large cell neuroendocrine carcinomas (LCNEC), 13 small cell lung cancers (SCLC), five atypical carcinoids (AC), and 10 typical carcinoids (TC) were enrolled in the study. LAT1 expression and Ki-67 labeling index of the NE tumors were analyzed by immunohistochemical staining. LAT1 was overexpressed in 52.4% of the LCNEC, in 46.2% of the SCLC, and in 25% of the AC. LAT1 expression in LCNEC was significantly associated with lymph node metastasis and poor outcome. Moreover, a significant correlation was found between LAT1 expression and Ki-67 in both LCNEC and SCLC. Expression of LAT1 tended to increase from low-grade to high-grade NE tumors. The present results suggest that LAT1 may play a significant role in cellular proliferation, lymph node metastasis, and poor outcome in patients with NE tumors of the lung.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440724     DOI: 10.1016/j.prp.2008.02.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  26 in total

1.  Increased expression of L-amino acid transporters in balloon cells of tuberous sclerosis.

Authors:  Byung-Chan Lim; Kyu-Young Cho; Joon-Seop Lim; Rae-Seop Lee; Hyung-Seok Kim; Myeong-Kyu Kim; Jae-Hyoo Kim; Young-Jong Woo; Jong-Keun Kim; Do Kyung Kim; Hyung-Ihl Kim; Kyung-Wha Lee; Min-Cheol Lee
Journal:  Childs Nerv Syst       Date:  2010-08-03       Impact factor: 1.475

Review 2.  L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.

Authors:  Qian Wang; Jeff Holst
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

3.  Role of the L-amino acid transporter-1 (LAT-1) in mouse trophoblast cell invasion.

Authors:  M K Chrostowski; B G McGonnigal; J P Stabila; J F Padbury
Journal:  Placenta       Date:  2010-04-24       Impact factor: 3.481

4.  Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Hisao Imai; Kimihiro Shimizu; Noriko Yanagitani; Noriaki Sunaga; Takeshi Hisada; Osamu Kawashima; Yosuke Kamide; Tamotsu Ishizuka; Yoshikatsu Kanai; Takashi Nakajima; Masatomo Mori
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

5.  A systemic review of PET and biology in lung cancer.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Noriaki Sunaga; Tamotsu Ishizuka; Kimihiro Shimizu; Nobuyuki Yamamoto
Journal:  Am J Transl Res       Date:  2011-07-27       Impact factor: 4.060

Review 6.  Altered glutamine metabolism and therapeutic opportunities for lung cancer.

Authors:  Amr Mohamed; Xingming Deng; Fadlo R Khuri; Taofeek K Owonikoko
Journal:  Clin Lung Cancer       Date:  2013-11-13       Impact factor: 4.785

7.  LAT-1 expression in pre- and post-implantation embryos and placenta.

Authors:  M K Chrostowski; B G McGonnigal; J P Stabila; J F Padbury
Journal:  Placenta       Date:  2009-02-04       Impact factor: 3.481

8.  CD98 increases renal epithelial cell proliferation by activating MAPKs.

Authors:  Nada Bulus; Chloe Feral; Ambra Pozzi; Roy Zent
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

9.  Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms.

Authors:  Yosuke Horita; Kyoichi Kaira; Tomonori Kawasaki; Yoshiaki Mihara; Shinichi Sakuramoto; Shigeki Yamaguchi; Kojun Okamoto; Shomei Ryozawa; Yoshikatsu Kanai; Masanori Yasuda; Tetsuya Hamaguchi
Journal:  In Vivo       Date:  2021 Jul-Aug       Impact factor: 2.155

10.  The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.

Authors:  Maihulan Maimaiti; Shinichi Sakamoto; Masahiro Sugiura; Manato Kanesaka; Ayumi Fujimoto; Keisuke Matsusaka; Minhui Xu; Keisuke Ando; Shinpei Saito; Ken Wakai; Yusuke Imamura; Keiichi Nakayama; Yoshikatsu Kanai; Atsushi Kaneda; Yuzuru Ikehara; Jun-Ichiro Ikeda; Naohiko Anzai; Tomohiko Ichikawa
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.